-
Trending Tickers: Cyclacel Pharmaceuticals (NASDAQ:CYCC), Loxo Oncology (NASDAQ:LOXO), Celladon Corporation (NASDAQ:CLDN), Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX), The McClatchy Company (NYSE:MNI)
On Friday shares of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) closed at $0.81. Company’s sales growth for last 5 years was 13.60%. On May 12 Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) reported its financial results for the first quarter ended March 31, 2015. The Company’s net loss applicable to common shareholders for the first quarter ended March 31, 2015…
-
Trending Stocks: Oasis Petroleum Inc. (NYSE:OAS), United States Steel Corp. (NYSE:X), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Thermon Group Holdings (NYSE:THR), Endeavour Silver (NYSE:EXK)
On Thursday shares of Oasis Petroleum Inc. (NYSE:OAS) closed at $17.94. Company’s sales growth for last 5 years was 105.60%. Equities research analysts at Nomura initiated coverage on shares of Oasis Petroleum (NYSE:OAS) in a research note issued to investors on Wednesday, TheFlyOnTheWall.com reports. United States Steel Corp. (NYSE:X) in last trading activity moved up…
-
Morning Buzz: Comverse (NASDAQ:CNSI), Kinross Gold Corporation (NYSE:KGC), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Twitter (NYSE:TWTR), Oracle Corporation (NYSE:ORCL)
On Thursday shares of Comverse, Inc. (NASDAQ:CNSI) closed at $22.98. Company’s EPS growth for next 5 years is recorded as 15.00%. Comverse Inc. (NASDAQ:CNSI) on Thursday reported fiscal fourth-quarter profit of $9.9 million. The Wakefield, Massachusetts-based company said it had net income of 45 cents per share. Earnings, adjusted for one-time gains and costs, were…
-
Worth Watching Stocks: Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Progress Software Corporation (NASDAQ:PRGS), Biogen Inc. (NASDAQ:BIIB), Sony Corp (NYSE:SNE)
On Tuesday shares of Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) closed at $4.45. On 26 March, Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) announced financial results for the three months and year ended December 31, 2014. Net loss for the year ended December 31, 2014, was $9.3 million, or $0.68 per share, compared with a net loss of…
-
Don’t Miss: Spark Therapeutics (NASDAQ:ONCE), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Baidu Inc (ADR) (NASDAQ:BIDU), Express Scripts Holding Company (NASDAQ:ESRX), Capella Education (NASDAQ:CPLA)
On Friday shares of Spark Therapeutics, Inc. (NASDAQ:ONCE) closed at $68.88. On Mar 18, Spark Therapeutics, Inc. (NASDAQ:ONCE) announced financial results for 2014. Net loss for the year ended December 31, 2014 was $24.3 million, as compared with a net loss of $57.3 million for the period from March 13, 2013 (inception) to December 31,…
-
Stocks to Watch: Neonode (NASDAQ:NEON), eBay Inc. (NASDAQ:EBAY), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Ormat Technologies Inc. (NYSE:ORA)
On Tuesday shares of Neonode, Inc. (NASDAQ:NEON) closed at $3.20. Company’s EPS growth for next 5 years is recorded as 25.00%. On 16 March, Neonode Inc. (NASDAQ:NEON), announce further details related to the agreement with Autoliv Development AB highlighted in Neonode’s recent fourth quarter and year ended December 31, 2014 financial results earnings release. Through…
-
Top News: Gilead Sciences Inc. (NASDAQ:GILD), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Demand Media (NYSE:DMD), Five Oaks Investment Corp. (NYSE:OAKS), General Motors (NYSE:GM)
On Thursday shares of Gilead Sciences Inc. (NASDAQ:GILD) closed at $101.44. Company’s sales growth for last 5 years was 28.80% and EPS growth for next 5 years is recorded as 14.48%. Gilead Sciences Inc. (NASDAQ:GILD) is collecting details of patients who buy generic versions of its blockbuster hepatitis-C medicine Sofosbuvir, on which it had signed…
-
Why Traders Are Watching: Cyclacel Pharmaceuticals (NASDAQ:CYCC), RCS Capital Corporation (NYSE:RCAP), Charter Financial Corporation (NASDAQ:CHFN), Linn Co (NASDAQ:LNCO), Ocwen Financial (NYSE:OCN)
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Board of Directors of Cyclacel Pharmaceuticals, Inc. declared a quarterly cash dividend in the amount of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock (“Preferred Stock”). The cash dividend will be payable on May 1, 2015 to the holders of record of the Preferred Stock as of the…
-
Market Movers: Williams Companies (NYSE:WMB), Cyclacel Pharmaceuticals (NASDAQ:CYCC), QLT Inc. (NASDAQ:QLTI), UQM Technologies Inc. (NYSEMKT:UQM), Solazyme (NASDAQ:SZYM)
On 25 February 2015, Williams Companies, Inc. (NYSE:WMB) has filed its Annual Report on Form 10-K for the year ended Dec. 31, 2014, with the Securities and Exchange Commission. On Friday shares of Williams Companies, Inc. (NYSE:WMB) closed at $49.04. Company’s sales growth for last 5 years was 7.70% and EPS growth for next 5…
-
Top Stocks: Analog Devices (NASDAQ:ADI), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Phillips 66 Partners LP (NYSE:PSXP), Exelon Corporation (NYSE:EXC), Gordmans Stores (NASDAQ:GMAN)
Analog Devices (NASDAQ: ADI) reported Q1 EPS of $0.63, $0.02 better than the analyst estimate of $0.61. Revenue for the quarter came in at $772 million versus the consensus estimate of $760.55 million. On Tuesday shares of Analog Devices, Inc. (NASDAQ:ADI) closed at $58.81. Company’s sales growth for last 5 years was 7.30% and EPS…